Tue, Aug 20 10:50am

Compare INCY

Incyte Corp [INCY]
$84.85 0.33 (0.39%)

INCY Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 17.88 Billion
INCY Description

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant, which Eli Lilly licenses, and oncology drug Iclusig for chronic myeloid leukemia. Incyte's pipeline includes a broad array of oncology and autoimmune programs, including next-generation JAK inhibitor itacitinib.

Visit Website

INCY Earnings

EPS 0.49 P/E Ratio 145.02
Previous Earnings Tue, Apr 30, 2019
Latest Earnings Tue, Jul 30, 2019 (21 days ago) +5.72%

INCY Dividend

Yield --
Ex-Date --
Pay Date --
History --

INCY Charts

1 Year
Dec 24, 2018
Jun 21, 2019

Symbol Price Day % YTD %
INCY $84.85 0.39% 33.50%

Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy